Russell Investments Group Ltd. Buys 14,302 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Russell Investments Group Ltd. increased its stake in Addus HomeCare Corporation by 39.2% in the first quarter, reaching a total of 50,790 shares valued at approximately $5.02 million.
• Addus HomeCare's latest earnings report showed an earnings per share (EPS) of $1.49, exceeding estimates, with revenue of $349.44 million, marking a year-over-year increase of 21.8%.
• Analysts have set a consensus rating of "Buy" for Addus HomeCare, with a target price averaging $138.63 following several recent upgrades from firms such as TD Cowen and Barclays.

Russell Investments Group Ltd. boosted its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 39.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,790 shares of the company's stock after acquiring an additional 14,302 shares during the period. Russell Investments Group Ltd. owned 0.28% of Addus HomeCare worth $5,023,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of ADUS. Natixis grew its stake in Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares in the last quarter. Bailard Inc. purchased a new stake in shares of Addus HomeCare in the 1st quarter valued at about $208,000. Heritage Family Offices LLP raised its holdings in shares of Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock valued at $239,000 after acquiring an additional 143 shares in the last quarter. Private Advisor Group LLC raised its holdings in shares of Addus HomeCare by 52.4% in the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock valued at $252,000 after acquiring an additional 875 shares in the last quarter. Finally, Hohimer Wealth Management LLC raised its holdings in shares of Addus HomeCare by 6.3% in the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock valued at $253,000 after acquiring an additional 152 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Trading Up 1.2%

NASDAQ:ADUS traded up $1.35 during mid-day trading on Wednesday, reaching $115.50. 121,663 shares of the company's stock traded hands, compared to its average volume of 201,508. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72. The firm has a market capitalization of $2.13 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 1.74 and a beta of 0.80. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The company has a 50 day moving average price of $112.03 and a 200-day moving average price of $107.01.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. During the same quarter in the prior year, the business earned $1.35 EPS. The business's revenue for the quarter was up 21.8% on a year-over-year basis. On average, sell-side analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the sale, the director directly owned 5,067 shares of the company's stock, valued at $582,350.31. The trade was a 23.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the sale, the chief executive officer directly owned 166,461 shares in the company, valued at approximately $19,134,691.95. This represents a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,310 shares of company stock worth $3,958,375. Company insiders own 4.50% of the company's stock.

Analysts Set New Price Targets

Several analysts have weighed in on the company. TD Cowen raised their price target on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Royal Bank Of Canada lifted their price target on Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research note on Friday, August 22nd. Barclays lifted their price target on Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a research note on Tuesday, August 19th. Macquarie reissued an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, JMP Securities reissued a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $138.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.